OpenAI on Thursday announced the acquisition of Astral, the developer of open source Python tools that include uv, Ruff and ty. It says that it plans to integrate them with Codex, its AI coding agent ...

Anthropic, a smaller rival started by OpenAI defectors, has found runaway success with its programming agent, Claude Code.

Nioh 3 gives you one of the most detailed character creators around, and that sounds great until you’re forty minutes deep adjusting cheekbones. So Ii you’re stuck trying to figure out what to make ...

Deutsche Telekom, Globe, Orange, Rakuten, Tata Communications, Telefónica, TELUS, and Vodafone are among more than 75 partners — including telecom providers, CPaaS platforms, systems integrators and ...

Anthropic is bringing Voice Mode to Claude Code, the company’s AI coding assistant for developers. The launch of voice mode marks a significant step toward more hands-free, conversational coding ...

International Business Machines stock is getting slammed Monday, becoming the latest perceived victim of rapidly developing AI technology, after Anthropic said its Claude Code tool could be used to ...

According to Claude on X (Twitter), Jon McBee’s Elisa is a block-based visual programming environment for children where snapped blocks trigger Claude agents that generate the underlying production ...

Seattle Public Schools is expanding its highly capable programming to two elementary schools — a landmark achievement for a community that has long voiced concerns about uneven distribution of ...

Before speaking with Professor Jae Woo Lee, I had gotten to know him through dozens of campus message board posts and professor reviews of his infamous course, Advanced Programming. According to a ...

I think the AI companies have more powerful models and releasing them piecemeal to steal compition spotlight. That said I like the direction OpenAI is going with this new model, if we can’t get AGI ...

GameSpot may get a commission from retail offers. Code Vein 2 features three different endings, but unlike many similar games, they don't require you to enter New Game Plus to access them. Instead, ...

The FDA approved a phase 3 trial for iSCIB1+ in advanced melanoma, focusing on progression-free survival as a surrogate endpoint. Phase 2 SCOPE trial showed a 24% improvement in progression-free ...